Creating the Smallest Effective Growth Hormone-Releasing Molecules | Research

The takeaway

Researchers created the smallest and most potent growth hormone secretagogues reported, with molecular weight under 500, and mapped the exact 3D shape needed for activity.

MW under 500
The smallest effective GH secretagogues reported, small enough for potential oral delivery

What the researchers found

Novel backbone-modified GH secretagogues with molecular weight under 500 were the most potent reported, with confirmed anabolic efficacy and a defined bioactive conformation.

Why it matters

Identifying the smallest effective GH-releasing molecules means these compounds could potentially be made into pills. Understanding the exact 3D shape needed for activity guides all future GH secretagogue drug design.

How the study worked

Researchers altered GHRP backbone structure to create new compounds. These were tested in vitro for GH release and in vivo in rodents for anabolic effects. NMR was used to determine the 3D structure of a potent cyclic analog.

What this study cannot tell us

Animal study in rodents. The most potent compounds may not maintain their potency in humans. Intermittent dosing was tested but long-term safety unknown.

How to read the evidence

Strong — comprehensive characterization including in vitro, in vivo rodent efficacy, and structural determination via NMR.

When this study was published

Published in 1995. This research directly contributed to the development of MK-677 and other oral GH secretagogues that followed.

The bigger picture

Small molecules under 500 MW can typically be taken as pills, while larger peptides need injections. This work was a critical step toward oral growth hormone secretagogues like MK-677, potentially replacing GH injections for certain conditions.

Questions still open

Do these small GH secretagogues maintain their potency when given orally to humans?
What are the long-term safety profiles of intermittent GH stimulation versus continuous GH administration?

Common questions

Why does molecular weight matter for drug design?

Molecules under 500 MW generally follow Lipinski's Rule of Five for oral bioavailability, meaning they can potentially be taken as pills rather than requiring injections.

What are growth hormone secretagogues?

They are compounds that stimulate the body to release its own growth hormone, as opposed to injecting synthetic GH directly. This approach may produce more natural GH release patterns.

Read the original research

Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation.

Proceedings of the National Academy of Sciences of the United States of America, 92(24), 11165-9

View on PubMed ↗

Citation

McDowell, R S; Elias, K A; Stanley, M S; Burdick, D J; Burnier, J P; Chan, K S; Fairbrother, W J; Hammonds, R G; Ingle, G S; Jacobsen, N E; Mortensen, D L; Rawson, T E; Won, W B; Clark, R G; Somers, T C. (1995). Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation.. Proceedings of the National Academy of Sciences of the United States of America, 92(24), 11165-9.